Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes.

Journal of the American College of Cardiology - 1 Sept 2001

Kennon S, Barakat K, Hitman G A, Price C P, Mills P G, Ranjadayalan K, Cooper J, Clark H, Timmis A D

Abstract excerpt

OBJECTIVES: This study was done to determine the effects of angiotensin-converting enzyme (ACE) inhibition and other clinical factors on troponin release in non-ST-elevation acute coronary syndrome (ACS). BACKGROUND: Troponin is now widely used as a marker of risk in ACS, but determinants of its release have not been defined. METHODS: This was a prospective cohort study of 301 consecutive patients admitted with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angina, Unstable
Share to Angiotensin-Converting Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endothelium, Vascular

Share to Logistic Models

Share to Myocardial Ischemia

Share to Renin-Angiotensin System

Share to Troponin

Share to Vasodilation

Source

Identifiers

PMID: 11527624
DOI: 10.1016/s0735-1097(01)01426-7

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes.PMID 11527624Read ↗

Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis.Semantic proximity Read ↗

Matrix metalloproteinases and their gene polymorphism in young ST-segment elevation myocardial infarction.Semantic proximity Read ↗

Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.Semantic proximity Read ↗

Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.Semantic proximity Read ↗

Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease.Semantic proximity Read ↗

Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.Semantic proximity Read ↗

Association between angiotensin II type 1 receptor polymorphism and sudden cardiac death in myocardial infarction.Semantic proximity Read ↗

The platelet phenotype in patients with ST-segment elevation myocardial infarction is different from non-ST-segment elevation myocardial infarction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.